Kymera Therapeutics

Kymera Therapeutics is Named one of FierceBiotech’s “Fierce 15” Companies of 2019

Cambridge, Mass. (September 23, 2019) – Kymera Therapeutics Inc., a biotechnology company advancing the field of targeted protein degradation to create next generation medicines, today announced that it has been named by FierceBiotech as one of 2019’s Fierce 15 biotechnology companies, designating